NDC properties for NDC 9 0054-0347
NDC item 00054034716
| NDC 9 | 0054-0347 |
|---|---|
| NDC 10 | 0054-0347-16 |
| NDC Item | 00054034716 |
| packaging | 40 TABLET, FILM COATED in 1 BOTTLE (0054-0347-16) |
| ANDA | ANDA201172 |
| COLORTEXT | WHITE(Off White) |
| Color | C48325 __ |
| FDA SPL set id | 611868 |
| Imprint code | 54524 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-03-31 |
| Marketing effective time low | 2012-04-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Biconvex |
| Shape | C48348 |
| Size | 9 mm |
NDC item 16571021404
| NDC 9 | 16571-214 |
|---|---|
| NDC 10 | 16571-214-04 |
| NDC Item | 16571021404 |
| packaging | 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16571-214-04) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 114445 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-10-10 |
| Marketing effective time low | 2013-10-09 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |
NDC item 42799020701
| NDC 9 | 42799-207 |
|---|---|
| NDC 10 | 42799-207-01 |
| NDC Item | 42799020701 |
| packaging | 40 TABLET in 1 BOTTLE (42799-207-01) |
| ANDA | ANDA203808 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 624893 |
| Imprint code | 207 |
| Labeler | Edenbridge Pharmaceuticals LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-12-20 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
NDC item 43386055004
| NDC 9 | 43386-550 |
|---|---|
| NDC 10 | 43386-550-04 |
| NDC Item | 43386055004 |
| packaging | 40 TABLET in 1 BOTTLE (43386-550-04) |
| ANDA | ANDA202044 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 423992 |
| Imprint code | NL;550 |
| Labeler | Lupin Pharmaceuticals,Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
NDC item 62135083420
| NDC 9 | 62135-834 |
|---|---|
| NDC 10 | 62135-834-20 |
| NDC Item | 62135083420 |
| packaging | 20 TABLET, FILM COATED in 1 BOTTLE (62135-834-20) |
| ANDA | ANDA202044 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 798224 |
| Imprint code | C;E;204 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-04-30 |
| Marketing status | active |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
NDC item 64980042602
| NDC 9 | 64980-426 |
|---|---|
| NDC 10 | 64980-426-02 |
| NDC Item | 64980042602 |
| packaging | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64980-426-02) |
| ANDA | ANDA202489 |
| COLORTEXT | PINK |
| Color | C48328 __ |
| FDA SPL set id | 717670 |
| Imprint code | TP;250 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-10-09 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Circular |
| Shape | C48348 |
| Size | 10 mm |